20,138 Shares in Revvity, Inc. (NYSE:RVTY) Bought by Raymond James Financial Inc.

Raymond James Financial Inc. purchased a new position in shares of Revvity, Inc. (NYSE:RVTY - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 20,138 shares of the company's stock, valued at approximately $2,248,000.

A number of other hedge funds also recently made changes to their positions in RVTY. Assetmark Inc. grew its holdings in shares of Revvity by 3,700.0% in the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock worth $30,000 after acquiring an additional 259 shares during the last quarter. Millstone Evans Group LLC acquired a new position in Revvity during the 4th quarter valued at $38,000. MassMutual Private Wealth & Trust FSB raised its stake in shares of Revvity by 55.9% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company's stock valued at $43,000 after purchasing an additional 138 shares in the last quarter. EverSource Wealth Advisors LLC raised its stake in Revvity by 33.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 522 shares of the company's stock worth $58,000 after acquiring an additional 131 shares in the last quarter. Finally, Principal Securities Inc. grew its holdings in shares of Revvity by 54.9% during the fourth quarter. Principal Securities Inc. now owns 598 shares of the company's stock worth $67,000 after purchasing an additional 212 shares during the last quarter. Institutional investors and hedge funds own 86.65% of the company's stock.

Analyst Ratings Changes

A number of analysts recently commented on the stock. JPMorgan Chase & Co. lowered their price objective on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a research report on Tuesday, April 29th. The Goldman Sachs Group dropped their price objective on shares of Revvity from $140.00 to $125.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. Sanford C. Bernstein cut Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price target on the stock. in a research report on Friday, January 10th. Barclays reduced their target price on Revvity from $140.00 to $110.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. Finally, UBS Group upgraded shares of Revvity from a "neutral" rating to a "buy" rating and lowered their price target for the stock from $145.00 to $115.00 in a report on Thursday. Four investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Revvity currently has a consensus rating of "Moderate Buy" and a consensus price target of $125.64.

Revvity Trading Down 0.4 %

Shares of RVTY traded down $0.36 during trading hours on Monday, hitting $93.64. 256,288 shares of the stock traded hands, compared to its average volume of 928,342. The business has a fifty day moving average of $102.80 and a 200-day moving average of $112.02. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. The firm has a market capitalization of $11.25 billion, a PE ratio of 42.36, a price-to-earnings-growth ratio of 3.82 and a beta of 1.07. Revvity, Inc. has a 1-year low of $88.53 and a 1-year high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last posted its earnings results on Monday, April 28th. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.96 by $0.05. The company had revenue of $664.76 million during the quarter, compared to analysts' expectations of $662.30 million. Revvity had a net margin of 9.81% and a return on equity of 7.68%. Revvity's quarterly revenue was up 2.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.98 EPS. Analysts expect that Revvity, Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be given a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.30%. The ex-dividend date of this dividend is Friday, July 18th. Revvity's dividend payout ratio (DPR) is presently 11.91%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.